Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-463-5 | CAS number: 646-06-0
Carcinogenicity
Administrative data
Description of key information
A retrospective data audit conducted on a final draft two-year chronic oral toxicity study in rat with 1,3-Dioxolane in drinking water is available. Although the study has never been finalised, it is concluded in the audit that the final draft report contained accurate toxicological information.
Repeated dose toxicity studies by oral and inhalation route are also available.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- Two-year chronic study was evaluated as Klimisch 2.
Justification for classification or non-classification
1,3-Dioxolane is not considered a systemic carcinogen and does not need to be classified for this endpoint (DSD and CLP).
Additional information
In the audit of the final draft 2 year chronic study in rats exposed via drinking water to 0%, 0.003% or 0.1% 1,3-Dioxolane it was concluded that, although the study has never been finalised, the study contains accurate toxicological information concerning long-term exposure to 1,3 -Dioxolane (administered to the drinking water). An increase in tumour incidence was not reported.
In addition, from the repeated dose toxicity studies (oral and inhalation), no indication for a carcinogenis potential was observed.
As a result of the absence of carcinogenic effects in the repeeated dose toxicity studies, including the chronic study, 1,3 -Dioxolane is considered to be non-carcinogenic.
Justification for selection of carcinogenicity via oral route endpoint:
In the audit of the final draft 2 year chronic study in rats exposed via drinking water to 0%, 0.003% or 0.1% 1,3-Dioxolane it was concluded that, although the study has never been finalised, the study contains accurate toxicological information concerning long-term exposure to 1,3-Dioxolane (administered to the drinking water). An increase in tumour incidence was not reported.
In addition, from the repeated dose toxicity studies (oral and inhalation), no indication for a carcinogenis potential was observed.
As a result of the absence of carcinogenic effects in the repeated dose toxicity studies, including the chronic study, 1,3-Dioxolane is considered to be non-carcinogenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
